Hematology in 10 min: Hemoglobinopathy &Thalassemia

preview_player
Показать описание
The complicated subject "Thalssemia" is presented in a simple lecture in 10 minutes.

Claremont, California
Рекомендации по теме
Комментарии
Автор

In September 2022, the FDA has approved ZYNTEGLO® (betibeglogene autotemcel), also known as beti-cel, a one-time gene therapy custom-designed to treat the underlying genetic cause of beta‑thalassemia in adult and pediatric patients who require regular red blood cell (RBC) transfusions. 89% achieved transfusion independence with Hb > 8 g/dL.
Common side effects: mommy comities, neutropenia, thrombocytopenia, anemia.

stanleykim
Автор

Thanks do much Dr for thy strives to make everything clear

emarupaul
Автор

Studying for im boards! Thanks for the refresher.

misteratoz
Автор

Thank you for this concise presentation

bakareolamide
Автор

What a great video! A wonderful explanation for a complicated topic. I found this to be extremely helpful while studying for my board exam. Thanks!!

josephkaizer
Автор

Doctor can you explain how to diagnose cases according to CBC and HLPC

muhammedsami
Автор

Wonderful explanation sir
I'm an indian

ravalshreyansh
welcome to shbcf.ru